SCHEMBL2637501

SCHEMBL2637501

O=C(NC1CC1)c1c(=O)[nH]n2c(=O)cc(-c3cccc(Cl)c3)[nH]c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.44
PDE4A P27815 2/20 0.41
PDE4B Q07343 2/20 0.41
PDE4C Q08493 2/20 0.41
PDE4D Q08499 1/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 4/20 0.41
CNR2 P34972 2/20 0.41
MAPT P10636 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TRPV1 Q8NER1 1/20 0.38
TP53 P04637 1/20 0.38
MDM2 Q00987 1/20 0.38
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637207 0.82 CNR2 (0.45) NPC1RAB9ACNR2MAPTMEN1
SCHEMBL2637666 0.80 POLB (0.43) NPC1RAB9ACNR2MEN1KMT2A
SCHEMBL2637448 0.79 NPC1 (0.46) NPC1RAB9AMEN1KMT2AKDM4A
SCHEMBL2637450 0.79 MEN1 (0.38) NPC1RAB9ACNR2MEN1KMT2A
SCHEMBL2637249 0.79 SMN1; SMN2 (0.50) NPC1RAB9AL3MBTL1MEN1KMT2A
SCHEMBL2637260 0.79 CNR2 (0.50) NPC1RAB9ACNR2MEN1KMT2A
SCHEMBL2637493 0.78 NHERF1 (0.46) NPC1RAB9ACNR2MAPTL3MBTL1
SCHEMBL2637188 0.77 MGAM (0.50) NPC1RAB9AMAPTL3MBTL1MEN1
SCHEMBL2637531 0.76 NPC1 (0.44) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL2638320 0.76 DHPS (0.46) NPC1RAB9AMEN1KMT2ATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed